Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Milpharm Limited, Ares Block, Odyssey Business Park, West End Road, Ruislip HA4 6QD, United Kingdom
Aurobeverine MR 200 mg modified-release capsules, hard.
| Pharmaceutical Form |
|---|
|
Modified-release capsule, hard. Creamy white body and creamy white cap, hard gelatin capsule (approximately 9.8 mm x 6.9 mm) filled with white to off white spherical pellets. |
Each capsule contains 200 mg mebeverine hydrochloride.
Excipient with known effect: Each capsule contains up to 23.81 mg sucrose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Mebeverine |
Mebeverine is a musculotropic antispasmodic with a direct action on the smooth muscle of the gastrointestinal tract, relieving spasm without affecting normal gut motility. |
| List of Excipients |
|---|
|
Capsule core: Sugar spheres (sucrose, maize starch) SR coating: Ethylcellulose Capsule shell: Gelatin |
Blister pack: PVC/PVdC – Aluminium blisters in cartons.
Pack sizes of blister: 30 and 60 capsules.
HDPE container pack: HDPE bottles fitted with round white screw type continuous thread cap.
Pack sizes of HDPE container: 250 capsules.
Not all pack sizes may be marketed.
Milpharm Limited, Ares Block, Odyssey Business Park, West End Road, Ruislip HA4 6QD, United Kingdom
PL 16363/0492
28/04/2017
| Drug | Countries | |
|---|---|---|
| AUROBEVERINE | United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
